Disparities in parental human papillomavirus (HPV) vaccine awareness and uptake among adolescents

Narissa J Nonzee, Susie B Baldwin, Yan Cui, Rita Singhal, Narissa J Nonzee, Susie B Baldwin, Yan Cui, Rita Singhal

Abstract

Trends in HPV vaccine awareness among parents of adolescent girls and boys (ages 13-17) and HPV vaccine uptake (≥1 dose) among girls (ages 13-17) were evaluated in Los Angeles County, California. Between 2007 and 2011, parental HPV vaccine awareness increased from 72% to 77% overall, with significant increases among mothers, Latinos, and respondents with daughters and Medi-Cal insured children. In 2011, parents who were male, older, less educated, Asian/Pacific Islander, and had sons remained significantly less likely to be aware. HPV vaccine initiation among daughters nearly doubled from 25% in 2007 to 48% in 2011, and girls who were older, uninsured, and had access-related barriers showed the largest improvements. In 2011, daughters who were younger and who had older and African American parents were at risk for low uptake. Thus, initiatives targeting male and younger adolescents, culturally-relevant information, and access to vaccination may help to reduce identified disparities.

Keywords: Adolescents; Awareness; Disparities; HPV vaccine; Human papillomavirus.

Conflict of interest statement

Conflicts of Interest

The authors have no potential conflicts of interest to disclose.

Copyright © 2017. Published by Elsevier Ltd.

References

    1. Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, et al. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines. Journal of the National Cancer Institute. 2015;107:djv086.
    1. McDougall JA, Madeleine MM, Daling JR, Li CI. Racial and ethnic disparities in cervical cancer incidence rates in the United States, 1992−2003. Cancer Causes & Control. 2007;18:1175–86.
    1. Benard VB, Johnson CJ, Thompson TD, Roland KB, Lai SM, Cokkinides V, et al. Examining the association between socioeconomic status and potential human papillomavirus‐ associated cancers. Cancer. 2008;113:2910–8.
    1. Reagan-Steiner S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2015. MMWR Morbidity and mortality weekly report. 2016;65
    1. Holman DM, Benard V, Roland KB, Watson M, Liddon N, Stokley S. Barriers to human papillomavirus vaccination among US adolescents: a systematic review of the literature. JAMA Pediatrics. 2014;168:76–82.
    1. Kessels SJM, Marshall HS, Watson M, Braunack-Mayer AJ, Reuzel R, Tooher RL. Factors associated with HPV vaccine uptake in teenage girls: a systematic review. Vaccine. 2012;30:3546–56.
    1. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Preventive Medicine. 2007;45:107–14.
    1. Los Angeles County Department of Public Health Office of Women’s Health and Office of Health Assessment & Epidemiology. Health Indicators for Women in Los Angeles County. Los Angeles, CA: ; 2017 [accessed 17.07.31]
    1. Los Angeles County Department of Public Health. Los Angeles County Health Survey. [accessed 17.04.25]
    1. Cui Y, Baldwin SB, Wiley DJ, Fielding JE. Human papillomavirus vaccine among adult women: disparities in awareness and acceptance. Am J Prev Med. 2010;39:559–63.
    1. Bastani R, Glenn BA, Tsui J, Chang LC, Marchand EJ, Taylor VM, et al. Understanding suboptimal human papillomavirus vaccine uptake among ethnic minority girls. Cancer Epidemiology, Biomarkers & Prevention. 2011;20:1463–72.
    1. Glenn BA, Tsui J, Singhal R, Sanchez L, Nonzee NJ, Chang LC, et al. Factors associated with HPV awareness among mothers of low-income ethnic minority adolescent girls in Los Angeles. Vaccine. 2015;33:289–93.
    1. Dorell CG, Yankey D, Santibanez TA, Markowitz LE. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics. 2011;128:830–9.
    1. Tiro JA, Tsui J, Bauer HM, Yamada E, Kobrin S, Breen N. Human papillomavirus vaccine use among adolescent girls and young adult women: an analysis of the 2007 California Health Interview Survey. Journal of women’s health. 2012;21:656–65.
    1. Guerry SL, De Rosa CJ, Markowitz LE, Walker S, Liddon N, Kerndt PR, et al. Human papillomavirus vaccine initiation among adolescent girls in high-risk communities. Vaccine. 2011;29:2235–41.
    1. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17 years–United States, 2011. MMWR Morbidity and mortality weekly report. 2012;61:671.
    1. Liddon N, Hood J, Wynn BA, Markowitz LE. Acceptability of human papillomavirus vaccine for males: a review of the literature. Journal of Adolescent Health. 2010;46:113–23.
    1. Centers for Disease Control and Prevention. National Center for Health Statistics. Use of Pap smears among women aged 18 and over, by selected characteristics: United States, selected years 1987–2013. 2015 . [accessed 17.04.25]
    1. Reiter PL, Gupta K, Brewer NT, Gilkey MB, Katz ML, Paskett ED, et al. Provider-verified HPV vaccine coverage among a national sample of Hispanic adolescent females. Cancer Epidemiology and Prevention Biomarkers. 2014 cebp-0979.
    1. Gilkey MB, Calo WA, Moss JL, Shah PD, Marciniak MW, Brewer NT. Provider communication and HPV vaccination: The impact of recommendation quality. Vaccine. 2016;34:1187–92.

Source: PubMed

Sponsors et collaborateurs

Les conditions médicales

Interventions en matière de drogue

3
S'abonner